Opinion

Video

Adverse Effect Management and the Role of Immunotherapy in NMIBC

Author(s):

Gordon A. Brown, DO,Siamak Daneshmand, MD

Experts on bladder cancer discusses strategies to minimize adverse effects and the role of immunotherapy in BCG-unresponsive NMIBC treatment paradigms.

Related Videos
Suzanne B. Merrill, MD, FACS, answers a question during a Zoom video interview
Urinary bladder | Image Credit: © magicmine - stock.adobe.com
3d rendered illustration - bladder cancer | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
Betty Wang, MD, discusses studies from the 2025 EAU meeting
Joshua J. Meeks, MD, PhD, answers a question during a Zoom video interview
Related Content
Human Body Organs (Urinary Bladder) | Image Credit: @ magicmine - stock.adobe.com
April 21st 2025

Nadofaragene firadenovec elicits high CR rate in phase 3 trial in Japan

Hannah Clarke
Treatment with nadofaragene led to a complete response rate of 75% at 3 months.
medical depiction of bladder cancer
May 31st 2023

Bladder Cancer Awareness Month: Dr. Kamat highlights the state of bladder cancer care

Urology Times staff
In this episode, Ashish M. Kamat, MD, MBBS, highlights the state of bladder cancer care in recognition of Bladder Cancer Awareness Month.
blur image background of corridor in hospital or clinic image | Image Credit: @ whyframeshot - stock.adobe.com
April 18th 2025

U.S. News & World Report Names Michigan Institute of Urology’s Town Center ASC Among 2025 Best Ambulatory Surgery Centers

Michigan Institute of Urology
Ambulatory surgery centers were evaluated based entirely on objective, risk-adjusted measures of their patients’ outcomes.
Dr. Lutz on sexual dysfunction, performance anxiety, and Peyronie's disease
May 26th 2022

Dr. Lutz on sexual dysfunction, performance anxiety, and Peyronie's disease

Urology Times staff
“We know that erectile dysfunction is really an important issue that can be a harbinger for other underlying cardiovascular or neurological health issues,” says Michael Lutz, MD.
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
April 17th 2025

Exploring new avenues in non–muscle invasive bladder cancer treatment

Urology Times staff
Three recent expert-led Clinical Forums explored current challenges and advancements in the management of non–muscle invasive bladder cancer.
FDA approval sought for Anktiva in papillary NMIBC
April 15th 2025

FDA approval sought for Anktiva in papillary NMIBC

Hannah Clarke
The sBLA is supported by data from cohort B of the pivotal QUILT-3.032 trial.
© 2025 MJH Life Sciences

All rights reserved.